Siemens Healthineers (ETR:SHL) Given a €38.00 Price Target at Independent Research

Share on StockTwits

Siemens Healthineers (ETR:SHL) has been assigned a €38.00 ($44.19) price objective by equities research analysts at Independent Research in a note issued to investors on Friday, Borsen Zeitung reports. The brokerage presently has a “neutral” rating on the stock. Independent Research’s price objective would indicate a potential upside of 8.02% from the company’s current price.

Other research analysts have also issued research reports about the company. Royal Bank of Canada set a €36.00 ($41.86) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Thursday, August 8th. Jefferies Financial Group set a €38.00 ($44.19) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Friday, May 3rd. Kepler Capital Markets set a €38.00 ($44.19) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday, May 6th. Nord/LB set a €36.00 ($41.86) price target on Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday, July 29th. Finally, Berenberg Bank set a €42.00 ($48.84) price target on Siemens Healthineers and gave the stock a “buy” rating in a research note on Friday, July 12th. Fourteen analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of €38.38 ($44.62).

Shares of Siemens Healthineers stock opened at €35.18 ($40.91) on Friday. Siemens Healthineers has a fifty-two week low of €31.90 ($37.09) and a fifty-two week high of €39.95 ($46.45). The firm has a market cap of $35.02 billion and a PE ratio of 24.62. The business’s fifty day moving average is €36.67 and its two-hundred day moving average is €36.61. The company has a quick ratio of 0.87, a current ratio of 1.30 and a debt-to-equity ratio of 55.12.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Featured Article: Trading Strategy Examples and Plans

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies
LegacyTexas Financial Group  Raised to Buy at BidaskClub
LegacyTexas Financial Group Raised to Buy at BidaskClub
Adverum Biotechnologies  PT Lowered to $8.00 at SunTrust Banks
Adverum Biotechnologies PT Lowered to $8.00 at SunTrust Banks


 
© 2006-2019 Zolmax.